Rami Musharrafieh

Xu Zhou, Chunlong Ma, Jun Wang, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral

Chunlong Ma, Jun Wang, Yanmei Hu, 2017, International journal of molecular sciences.

Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein.

Jun Wang, Yanmei Hu, Naoya Kitamura, 2021, Journal of medicinal chemistry.

Development of broad-spectrum enterovirus antivirals based on quinoline scaffold.

Jun Wang, Yanmei Hu, Naoya Kitamura, 2020, Bioorganic chemistry.

Enterovirus D68 antivirals: past, present and future.

Jun Wang, Yanmei Hu, Madeleine Zheng, 2020, ACS infectious diseases.

A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68.

Chunlong Ma, Jun Wang, Yanmei Hu, 2019, ACS infectious diseases.

Exploring Ugi-Azide Four-Component Reaction Products for Broad-Spectrum Influenza Antivirals with a High Genetic Barrier to Drug Resistance

C. Hulme, Chunlong Ma, Jun Wang, 2018, Scientific Reports.

An M2‐V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine‐sensitive and ‐resistant influenza A viruses

W. DeGrado, D. Smee, Chunlong Ma, 2017, Antiviral research.

Investigation of the Drug Resistance Mechanism of M2-S31N Channel Blockers through Biomolecular Simulations and Viral Passage Experiments.

Chunlong Ma, Jun Wang, G. Lambrinidis, 2020, ACS pharmacology & translational science.

Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.

Chunlong Ma, Jun Wang, Rami Musharrafieh, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Profiling the in vitro drug‐resistance mechanism of influenza A viruses towards the AM2‐S31N proton channel blockers

Chunlong Ma, Jun Wang, Rami Musharrafieh, 2018, Antiviral research.

In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses.

Chunlong Ma, Jun Wang, Yanmei Hu, 2018, Journal of medicinal chemistry.

Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development.

Jun Wang, H. Yin, Yanmei Hu, 2019, Current medicinal chemistry.

Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift

Yana Safonova, D. Burton, B. Briney, 2023, bioRxiv.

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause severe disease

Lisa E. Gralinski, Yana Safonova, D. Burton, 2022, bioRxiv.

Germline-targeting chimpanzee SIV Envelopes induce V2-apex broadly neutralizing-like B cell precursors in a rhesus macaque infection model

Yana Safonova, B. Hahn, F. Bibollet-Ruche, 2023, bioRxiv.

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

Lisa E. Gralinski, Yana Safonova, D. Burton, 2023, Immunity.